# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-04T13:49:00.518171
**Route:** OpenRouter + LaTeX
**Paper Hash:** 3eb2e2a876ded2e8
**Tokens:** 16696 in / 1422 out
**Response SHA256:** 834307475b2688a4

---

I checked the draft only for **fatal** problems in: (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency. I do **not** see any fatal errors that would make the empirical design impossible to execute or that would embarrass you at a journal.

### 1) DATA–DESIGN ALIGNMENT (CRITICAL)
- **Treatment timing vs. data coverage:** Treatment is defined as **Post = 1{year ≥ 2018}** and DVF coverage is stated as **2014–2025** (with 2025 partial through Oct 2025). This is aligned: you have multiple pre-years (2014–2017) and multiple post-years (2018+).
- **Post-treatment observations:** Yes—there are many post-treatment years for the 2018-treated design.
- **Treatment definition consistency:** The paper is consistent that the main DiD uses a single Post cutoff at 2018. You explicitly acknowledge that coding the 22 later-designated communes as treated from 2018 is a deliberate “conservative” choice. That is not a data impossibility; it is a definitional choice that is disclosed.

**No fatal data–design misalignment found.**

---

### 2) REGRESSION SANITY (CRITICAL)
I scanned all reported regression tables:

- **Table 1 (Main results; \Cref{tab:main_results})**
  - Coefficients are in plausible ranges for log outcomes (e.g., 0.06–0.21).
  - Standard errors are plausible and nowhere near absurd magnitudes; no cases of SE ≫ 100×|coef|.
  - R² values are all in [0,1].
  - N is reported.

- **Heterogeneity table (\Cref{tab:heterogeneity})**
  - Coefficients/SEs plausible; no extreme values.
  - R² values in [0,1].
  - N is reported.

- **Robustness table (\Cref{tab:robustness})**
  - Coefficients/SEs plausible; N reported.

**No fatal regression-output issues found (no NaN/Inf/NA; no impossible R²; no absurd SE patterns).**

---

### 3) COMPLETENESS (CRITICAL)
- No “TBD/TODO/XXX/PLACEHOLDER/NA” appears in any table entries where numbers should be.
- Regression tables report **N** and **standard errors**.
- All figures/tables referenced in the text appear to have corresponding LaTeX figure/table environments in the source (e.g., event study, trends, placebo, leave-one-region-out).
- Methods described (TWFE DiD, event study, placebo tests, leave-one-region-out) have corresponding displayed results (figures and/or tables) in the draft.

**No fatal incompleteness detected from the provided LaTeX source.**

---

### 4) INTERNAL CONSISTENCY (CRITICAL)
- **Timing consistency:** Treatment defined as 2018 throughout, with a coherent timeline (announcement late 2017; list March 2018; Post starts 2018).
- **Sample period consistency:** Main results are described for 2014–2025; event study is described through 2024 (not using partial 2025), which is consistent with your note that 2025 is partial.
- **Text–table agreement:** The narrative matches the numbers in \Cref{tab:main_results} (e.g., 0.0728 with SE 0.0156; 0.0600 with SE 0.0188; transaction-level near zero; volume 0.1526 with SE 0.0802).

**No fatal internal contradictions found.**

---

ADVISOR VERDICT: PASS